Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
slight decrease » slight increase (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
slight decrease » slight increase (Expand Search)
-
2561
-
2562
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
2563
-
2564
-
2565
-
2566
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2567
-
2568
-
2569
-
2570
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2571
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2572
-
2573
-
2574
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
2575
-
2576
-
2577
-
2578
-
2579
-
2580